Can Patient Reported Outcome (PRO) measure scores predict patient retention in clinical trials?

Our latest submission to the DIA 2014 Annual General Meeting

Maintaining high levels of patient recruitment, adherence and retention is essential for the successful completion of a clinical trial, yet it remains a significant challenge faced by researchers.  Poor patient adherence and retention can adversely affect a trial by lengthening timelines, adding cost and risk to the validity of the data and delaying product approval.  In this presentation using findings from logic regression analysis of loss to follow-up of a patient survey using the Diabetes Health Profile (DHP), we will discuss how DHP scores in combination with health-related problems and other contextual factors may provide unique insights to risk profiling of patient retention in a clinical trial. We will explore the challenges of developing such a model and demonstrate using the principles from behavioural economics, how knowledge of these factors can be optimised to influence patient retention in a clinical trial.

See our related posting: How are patient decisions formed to stay or drop out from a clinical trial?

 



Categories: Diabetes Health Profile, Patient reported experience

Tags: , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: